1-8 of 8
Kaili Ren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study

Noemi Puig, Vania T.M. Hungria, Ajai Chari, Faith E. Davies, Gordon Cook, Roman Hájek, Kathryn E. Morgan, Jim Omel, Evangelos Terpos, Michael A. Thompson, Saad Usmani, Jorge Vela-Ojeda, Katja Weisel, Mira Armour, Kaili Ren, Dasha Cherepanov, Dawn Marie Stull, Jesus Berdeja
Journal: Blood
Blood (2022) 140 (Supplement 1): 4269–4272.
https://doi.org/10.1182/blood-2022-163074
Published: 2022
Journal Articles

The INSURE Study (INSIGHT MM, UVEA-IXA, REMIX): A Pooled Analysis of Relapsed/Refractory Multiple Myeloma (RRMM) Patients (pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice

Xavier Leleu, Mario Boccadoro, Hans C. Lee, Jeffrey A. Zonder, Magaret Macro, Karthik Ramasamy, Cyrille Hulin, Jiri Silar, Matyáš Kuhn, Kaili Ren, Nawal Bent-Ennakhil, Sylvie Bouillie, Dasha Cherepanov, Dawn Marie Stull, Evangelos Terpos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2701.
https://doi.org/10.1182/blood-2021-150150
Published: 2021
Journal Articles

Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1 Study

Roman Hajek, Prof, MD PhD, Jiri Minarik, MD PhD, Jan Straub, MD, Ludek Pour, MD, Alexandra Jungova, Jesus G. Berdeja, MD, Mario Boccadoro, Lucie Brožová, MSc, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Frits van Rhee, MD PhD, Jorge Vela-Ojeda, MD PhD, Michael A. Thompson, MD PhD FASCO, Rafat Abonour, MD, Ajai Chari, MD, Gordon Cook, MB ChB, PhD FRCP(Glas), FRCPath, Caitlin L. Costello, MD, Faith E. Davies, MD, Vania T.M. Hungria, MD PhD, Hans C. Lee, MD, Xavier Leleu, MD PhD, Noemi Puig, MD PhD, Robert M. Rifkin, MD, Evangelos Terpos, MD PhD, Saad Z. Usmani, MD FACP, Katja C. Weisel, MD, Jeffrey A. Zonder, Magda Bařinová, MSc, Matyáš Kuhn, MSc, Jiri Silar, MSc, Lenka Capkova, Kenny Galvez, MD, Jin Lu, MDProf, Tomas Skacel, MD, Jennifer Elliott, Brittany Demers, BS, BA, Dawn Marie Stull, Pharm.D., BCOP, Kaili Ren, PhD, Vladimir Maisnar, MD PhD MBA
Journal: Blood
Blood (2019) 134 (Supplement_1): 1845.
https://doi.org/10.1182/blood-2019-126606
Published: 2019
Journal Articles

Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study

Vania T.M. Hungria, MD PhD, Hans C. Lee, MD, Rafat Abonour, MD, Robert M. Rifkin, MD, Evangelos Terpos, MD PhD, Xavier Leleu, MD PhD, Caitlin L. Costello, MD, Frits van Rhee, MD PhD, Katja C. Weisel, MD, Noemi Puig, MD PhD, Jesus G. Berdeja, MD, Gordon Cook, MB ChB, PhD FRCP(Glas), FRCPath, Saad Z. Usmani, MD FACP, Michael A. Thompson, MD PhD FASCO, Mario Boccadoro, Jeffrey A. Zonder, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Roman Hajek, Prof, MD PhD, Suzanne R. Fanning, DO, Kevin Boyd, MB BS, BSc, MRCP, FRCPath, PhD, Jim Omel, MD, Mira Armour, BSc, Kathryn E. Morgan, Ronak S. Patel, Gary L. Carlson, Renda H. Ferrari, PhD, Dawn Marie Stull, Pharm.D., BCOP, Kaili Ren, PhD, Dasha Cherepanov, PhD, James V. Pottala, PhD, Ajai Chari, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1887.
https://doi.org/10.1182/blood-2019-125749
Published: 2019
Journal Articles

Comparing Bortezomib-Lenalidomide-Dexamethasone (VRd) with Carfilzomib-Lenalidomide-Dexamethasone (KRd) in the Patients with Newly Diagnosed Multiple Myeloma (NDMM) in Two Observational Studies

Bin Li, PhD, Kaili Ren, PhD, Lei Shen, PhD, Peijie Hou, PhD, Zhenqiang Su, PhD, Alessandra Di Bacco, PhD, Jin-Liern Hong, PhD, Aaron Galaznik, PhD, Ajeeta B Dash, PhD, Victoria Crossland, PhD, Paul Dolin, DPhil, Sandor Szalma, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3298.
https://doi.org/10.1182/blood-2018-99-115017
Published: 2018
Journal Articles

Ixazomib Plus Lenalidomide-Dexamethasone (IRd) in Relapsed/Refractory Multiple Myeloma (MM) Patients (Pts) - Effectiveness in Routine Clinical Practice Is Similar to the Efficacy in the Phase 3 Tourmaline-MM1 Trial: A Pooled Analysis from the Insight MM Observational Study and the Czech Registry of Monoclonal Gammopathies (RMG)

Roman Hajek, MD PhD, Evangelos Terpos, MD PhD, Hans C. Lee, MD, Ajai Chari, MD, Caitlin L. Costello, MD, Noemi Puig, MD PhD, Xavier Leleu, MD PhD, Jesus G. Berdeja, MD, Faith E. Davies, MD, Katja Weisel, MD, Saad Z. Usmani, MD, Vania T. M. Hungria, MD PhD, Mario Boccadoro, MD, Robert M Rifkin, MD, Jeffrey A Zonder, MD, Gordon Cook, Lucie Brožová, MSc, Magda Bařinová, MSc, Kaili Ren, PhD, Roxanne Cacioppo, Tomas Skacel, MD PhD, Dawn Marie Stull, Pharm.D., BCOP, Vladimir Maisnar, MD TMD, MBA
Journal: Blood
Blood (2018) 132 (Supplement 1): 1971.
https://doi.org/10.1182/blood-2018-99-113441
Published: 2018
Journal Articles

Transplant Status Does Not Impact the Selection of Induction Regimens for Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) in the Insight MM Prospective, Observational Study

Saad Z. Usmani, MD, Vania T. M. Hungria, MD PhD, Xavier Leleu, MD PhD, Hans C. Lee, MD, Faith E. Davies, MD, Caitlin L. Costello, MD, Robert M Rifkin, MD, Katja Weisel, MD, Ajai Chari, MD, Noemi Puig, MD PhD, Mario Boccadoro, MD, Gordon Cook, Jesus G. Berdeja, MD, Jeffrey A Zonder, MD, Michael A. Thompson, MD PhD FASCO, Rafat Abonour, MD, Jorge Vela-Ojeda, MD PhD, Roman Hajek, MD PhD, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Jim Omel, MD, Brittany Demers, BS, BA, Dorothy Romanus, RPh, PhD, Kaili Ren, PhD, Tomas Skacel, MD PhD, Dawn Marie Stull, Pharm.D., BCOP, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3289.
https://doi.org/10.1182/blood-2018-99-112846
Published: 2018
Journal Articles

Uncovering the Blind Spot of Clinical Trials: First Report of Baseline Characteristics of Newly Diagnosed (ND) and Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients (Pts) in Insight-MM, a Global, Prospective, Observational Study

Evangelos Terpos, MD PhD, Ajai Chari, MD, Robert M Rifkin, MD, Rafat Abonour, MD, Jesus G. Berdeja, MD, Mario Boccadoro, Gordon Cook, MD PhD, Caitlin Costello, MD, Saulius Girnius, MD, Hartmut Goldschmidt, MD, Roman Hájek, MD, Vania T M Hungria, MD PhD, Hans C. Lee, MD, Xavier Leleu, MD PhD, Jim Omel, MD, Andrew Spencer, MD, Michael A Thompson, MD, Saad Z Usmani, MD, Jorge Vela-Ojeda, MD PhD, Jeffrey A Zonder, MD, Liviu Niculescu, MD, Stephen Noga, MD, Tomas Skacel, MD, Roxanne Cacioppo, Brittany Sickler, BA, BS, Shawn Yu, Kaili Ren, PhD, Katarina Luptakova, MD, Dawn Marie Stull, Faith E. Davies, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5419.
https://doi.org/10.1182/blood.V130.Suppl_1.5419.5419
Published: 2017